Saturday, October 3, 2026

USD/CNH Bearish By 2% In The Last 21 Sessions

ViaNews Editorial Team

November 29, 2023

USD/CNH Bearish By 2% In The Last 21 Sessions

(VIANEWS) - USD/CNH (USDCNH) has been up by 2.57% for the last 21 sessions. At 14:06 EST on Wednesday, 29 November, USD/CNH (USDCNH) is $7.13.

USD/CNH's yearly highs and lows, it's 0.29% up from its 52-week low and 0.01% down from its 52-week high.

News about

  • Eur/usd remains capped below 1.0950, eyes on eurozone inflation, US GDP data. According to FXStreet on Monday, 27 November, "The downside risks to growth in Germany, Europe's largest economy might exert some selling pressure on the Euro (EUR) and act as a headwind for the EUR/USD pair. "
  • According to FXStreet on Monday, 27 November, "Further north, EUR/USD might face resistance around the August top of 1.1064 (August 10) and another weekly peak of 1.1149 (July 27), all preceding the 2023 high of 1.1275 (July 18)."
  • Eur/usd price analysis: continues the winning streak on weaker US dollar, trades near 1.0950. According to FXStreet on Monday, 27 November, "If the pair manages to break through that level, it could empower EUR/USD bulls to tackle the resistance zone near the psychological level of 1.1000.", "The technical signals for the EUR/USD pair are in favor of the ongoing upward movement. "
  • Eur/usd refreshes multi-month peak as fed rate cut bets continue to undermine the USD. According to FXStreet on Tuesday, 28 November, "This will be followed by the flash Eurozone CPI report on Thursday and the US Core PCE Price Index - the Fed's preferred inflation gauge - on Thursday, which, in turn, will drive the EUR/USD pair in the near term.", "Adding to this, the increasing likelihood of earlier rate cuts by the Fed in 2024 compared to the European Central Bank (ECB) turns out to be another factor acting as a tailwind for the EUR/USD pair."

More news about USD/CNH (USDCNH).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI-Driven Drug Development Meets Biotech Deal-Making and Regulatory Catalysts
AI-designed therapeutics (Insilico's rentosertib showing biological-age reductions) are moving into the clinical mainstream. Large-cap biotech is simultaneously reallocating capital through M&A (Lilly–Merida, $2.9B) and government funding (BARDA–Basilea), while trial failures (ziltivekimab, a 9.4% Novo Nordisk share drop) and upcoming FDA catalysts (the ivonescimab PDUFA on 2026-11-14) drive volatility. The wider AI regulatory and legal climate (Tesla Cybercab probe, xAI's Minnesota loss, OpenAI suits) is tightening, though QAIAx's micro-cap trial claims are speculative and weakly connected.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,327 source documents archived
Query this data → isubstrate.com